Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes - D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81 |
| Author(s) : D'Alessio DA , Denney AM , Hermiller LM , Prigeon RL , Martin JM , Tharp WG , Saylan ML , He Y , Dunning BE , Foley JE , Pratley RE |
| Ref : J Clinical Endocrinology Metab , 94 :81 , 2009 |
| Abstract : D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81 |
| ESTHER : D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81 |
| PubMedSearch : D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81 |
| PubMedID: 18957505 |
| Title : Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes inadequately controlled by glyburide monotherapy - Pratley_2009_Diabetes.Obes.Metab_11_167 |
| Author(s) : Pratley RE , Kipnes MS , Fleck PR , Wilson C , Mekki Q |
| Ref : Diabetes Obes Metab , 11 :167 , 2009 |
| Abstract : Pratley_2009_Diabetes.Obes.Metab_11_167 |
| ESTHER : Pratley_2009_Diabetes.Obes.Metab_11_167 |
| PubMedSearch : Pratley_2009_Diabetes.Obes.Metab_11_167 |
| PubMedID: 19125778 |
| Title : Alogliptin: a new, highly selective dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes - Pratley_2009_Expert.Opin.Pharmacother_10_503 |
| Author(s) : Pratley RE |
| Ref : Expert Opin Pharmacother , 10 :503 , 2009 |
| Abstract : Pratley_2009_Expert.Opin.Pharmacother_10_503 |
| ESTHER : Pratley_2009_Expert.Opin.Pharmacother_10_503 |
| PubMedSearch : Pratley_2009_Expert.Opin.Pharmacother_10_503 |
| PubMedID: 19191685 |
| Title : Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus - Gilbert_2009_Am.J.Med_122_S11 |
| Author(s) : Gilbert MP , Pratley RE |
| Ref : American Journal of Medicine , 122 :S11 , 2009 |
| Abstract : Gilbert_2009_Am.J.Med_122_S11 |
| ESTHER : Gilbert_2009_Am.J.Med_122_S11 |
| PubMedSearch : Gilbert_2009_Am.J.Med_122_S11 |
| PubMedID: 19464424 |
| Title : Expanding treatment options for type 2 diabetes: the old and the new - Pratley_2009_Diabetes.Educ_35 Suppl 1_4S |
| Author(s) : Pratley RE |
| Ref : Diabetes Educ , 35 Suppl 1 :4S , 2009 |
| Abstract : Pratley_2009_Diabetes.Educ_35 Suppl 1_4S |
| ESTHER : Pratley_2009_Diabetes.Educ_35 Suppl 1_4S |
| PubMedSearch : Pratley_2009_Diabetes.Educ_35 Suppl 1_4S |
| PubMedID: 19218561 |
| Title : Overview of glucagon-like peptide-1 analogs and dipeptidyl peptidase-4 inhibitors for type 2 diabetes - Pratley_2008_Medscape.J.Med_10_171 |
| Author(s) : Pratley RE |
| Ref : Medscape J Med , 10 :171 , 2008 |
| Abstract : Pratley_2008_Medscape.J.Med_10_171 |
| ESTHER : Pratley_2008_Medscape.J.Med_10_171 |
| PubMedSearch : Pratley_2008_Medscape.J.Med_10_171 |
| PubMedID: 18769687 |
| Title : Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors - Pratley_2008_Rev.Diabet.Stud_5_73 |
| Author(s) : Pratley RE , Gilbert M |
| Ref : Rev Diabet Stud , 5 :73 , 2008 |
| Abstract : Pratley_2008_Rev.Diabet.Stud_5_73 |
| ESTHER : Pratley_2008_Rev.Diabet.Stud_5_73 |
| PubMedSearch : Pratley_2008_Rev.Diabet.Stud_5_73 |
| PubMedID: 18795210 |
| Title : The cannabinoid CB1 receptor is expressed in pancreatic delta-cells - Tharp_2008_Biochem.Biophys.Res.Commun_372_595 |
| Author(s) : Tharp WG , Lee YH , Maple RL , Pratley RE |
| Ref : Biochemical & Biophysical Research Communications , 372 :595 , 2008 |
| Abstract : Tharp_2008_Biochem.Biophys.Res.Commun_372_595 |
| ESTHER : Tharp_2008_Biochem.Biophys.Res.Commun_372_595 |
| PubMedSearch : Tharp_2008_Biochem.Biophys.Res.Commun_372_595 |
| PubMedID: 18505678 |